This 2 weeks timing already reported as a risk period for clinical events (1) was characterized by the lowest HLA-DR expression on monocyte subsets associated with the deepest CD4 and CD8 T-cells lymphopenia. This evidence concerns the gene CD4 and lymphopenia.